FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
Chippewa Herald7h
Lake Holcombe senior Lee back on court amid leukemia battle
Still dealing with a major diagnosis, the girls basketball and volleyball player is making efforts to be back on the floor.
ashlandsource21h
Ashland colon cancer screening survey shows higher than expected rates of testing
Ashland County health officials are seeking grant money to increase at-home colorectal cancer screening kits — despite a ...
Backed by Mayo Clinic, Nutrix’s hardware monitors worker stress
Stress isn’t just bad for you — it’s also bad for your employer. Factoring in absenteeism, diminished productivity, turnover, ...
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
KSNF on MSN20h
Dwyane Wade reveals cancer diagnosis, kidney surgery
Wade, who turned 43 earlier this month, said his father’s journey with prostate cancer inspired him to see a doctor after ...
US drug regulator approves first new type of pain pill in more than 20 years
The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...
FDA approves first new non-opioid pain pill in 20 years—how it works
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
HealthDay on MSN20h
Fasting glucose, age, male sex, BMI all linked to diabetes development
Fasting plasma glucose (FPG), age, body mass index (BMI) and male sex are all associated with development of diabetes, according to a study published online Jan. 23 in JAMA Network Open.